Helicobacter pylori and gut bacterial DNA and associated macromolecular complexes

Helicobacter pylori and gut bacterial DNA and associated macromolecular complexes represent a broad category of biological structures essential for the survival and pathogenicity of H. pylori and other gut bacteria. These targets include genomic DNA, which contains unmethylated CpG motifs that are recognized by the host's Toll-like receptor 9 (TLR9), triggering an innate immune response (PubMed, 2021). Macromolecular complexes within this category include the bacterial 70S ribosome, which is responsible for protein synthesis, and DNA gyrase, which manages DNA supercoiling during replication (StatPearls, 2023). These structures are the primary targets for antimicrobial therapy; for example, macrolides like clarithromycin bind to the ribosome to inhibit translation, while fluoroquinolones inhibit DNA gyrase (NIH, 2022). H. pylori infection is a major cause of chronic gastritis and peptic ulcer disease and is a classified Type I carcinogen for gastric adenocarcinoma (Mayo Clinic, 2023). Eradication of these bacterial components is necessary to prevent disease progression and recurrence. However, the therapeutic targeting of these complexes is increasingly complicated by the global rise of antibiotic-resistant strains. Additionally, the use of broad-spectrum agents against these targets can lead to collateral damage to the beneficial gut microbiota, resulting in dysbiosis.

Other names

H. pylori DNABacterial DNABacterial macromolecular complexesMicrobial DNA-protein complexesHelicobacter pylori genomic material

Inhibition of bacterial protein synthesis via the 50S ribosomal subunit, inhibition of DNA replication via DNA gyrase and topoisomerase IV, and induction of innate immune signaling via Toll-like receptor 9.